• Explore /
  • Poster
  • / Gene expression in circulating tumor cells (CTC) and plasma androgen receptor (<em>AR</em>) gene copy number (CN) for castration-resistant prostate cancer (CRPC) patients (pts) treated with cabazitaxel.

Gene expression in circulating tumor cells (CTC) and plasma androgen receptor (AR) gene copy number (CN) for castration-resistant prostate cancer (CRPC) patients (pts) treated with cabazitaxel.

Abstract Poster

Authors

null

Giorgia Gurioli

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Giorgia Gurioli , Vincenza Conteduca , Umberto Basso , Giuseppe Fornarini , Alessandra Mosca , Maurizio Nicodemo , Giuseppe Luigi Banna , Cristian Lolli , Giuseppe Schepisi , Stefania Gargiulo , Amelia Altavilla , Sara Testoni , Emanuela Scarpi , Ugo De Giorgi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research

Clinical Trial Registration Number

NCT03381326

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 154)

Abstract #

154

Poster Bd #

G12

Abstract Disclosures

Similar Posters

First Author: Alicia K. Morgans

First Author: Paul Vincent Viscuse

First Author: Arpit Rao

First Author: Johann S. De Bono